Bicyclic aromatic derivatives, method for preparing them, and their use in human and veterinary medicine and in cosmetics

Claim 2

Bicyclic aromatic compound, having the formula ##STR23## in which n=0 or 1, R' represents hydrogen, OH, alkoxy having from 1 to 4 carbon atoms, or acyloxy having from 1 to 4 carbon atoms; R" represents hydrogen or alkoxy having from 1 to 4 carbon atoms; or R' and R" taken together form an oxo (═O), methano (═CH 2 ) or hydroxyimino (═N--OH) radical; R represents --CH 2 OH or --COR 7 ; R 7 represents hydrogen, --OR 8 or ##STR24## in which R 8 represents hydrogen, alkyl having from 1 to 20 carbon atoms, monohydroxyalkyl, polyhydroxyalkyl phenyl, phenyl substituted with at least one halogen atom, --OH, --NO 2 , lower alkyl having 1-6 carbon atoms, trifluoromethyl or a carboxylic acid function, benzyl, phenethyl, a residue of glucose, mannose, erythrose or galactose, or ##STR25## where p is 1, 2 or 3 and r' and r" represent hydrogen, lower alkyl having 1-6 carbon atoms, monohydroxyalkyl monohydroxyalkyl interrupted by a heteroatom, polyhydroxyalkyl, aryl or benzyl, amino acid residue, a residue of glucosamine, galactosamine, mannosamine or meglumine or when taken together with the nitrogen atom to which they are attached form a heterocycle; A represents methylene or dimethylene, unsubstituted or substituted with lower alkyl having 1-6 carbon atoms; R 1 , R 2 , R 3 and R 4 represent hydrogen or lower alkyl having 1-6 carbon atoms; R 1 and R 3 taken together are capable of forming a methylene or dimethylene radical, A representing a dimethylene radical; R 5 and R 6 represent hydrogen or methyl; and the salts of said compound, as well as their optical and geometric isomers.

Claim 3

The compound of claim 1, wherein R 8 is selected from the group consisting of methyl, ethyl, isopropyl, butyl, tert. butyl, 2-ethylhexyl, isooctyl, dodecyl, hexadecyl and octadecyl.

Claim 4

The compound of claim 1, wherein said monohydroxyalkyl is 2-hydroxyethyl, 2-hydroxypropyl or 2-hydroxyethoxyethyl.

Claim 5

The compound of claim 1, wherein said polyhydroxyalkyl is 2,3-dihydroxypropyl, 1,3-dihydroxy-2-propyl or pentaerythritol residue.

Claim 6

The compound of claim 1, wherein said alkoxy is methoxy, isopropoxy, butoxy or tert. butoxy.

Claim 7

The compound of claim 1, wherein r' and r" taken together with the nitrogen atom to which they are attached form a piperidino, piperazino, morpholino, pyrrolidino or 4-(2-hydroxyethyl) piperazino radical.

Claim 8

The compound of claim 1 having the formula: ##STR26## in which: A, R, R 1 -R 4 , R' and R" have the same meanings as those provided in claim 1.

Claim 9

The compound of claim 1 having the formula: ##STR27## in which: A, R, R 1 -R 6 , R' and R" have the same meanings as those provided in claim 1.

Claim 10

The compound of claim 1 having the formula ##STR28## in which A represents CH 3 --CH< or dimethylene; R' represents OH and R" represents hydrogen, or R' and R", taken together, form an oxo radical (═O); and R' 7 represents hydrogen, --OR' 8 , or ##STR29## R' 8 represents hydrogen or lower alkyl having 1-6 carbon atoms; r' represents hydrogen and r" represents lower alkyl having 1-6 carbon atoms or a substituted phenyl radical, or r' and r" taken together with the nitrogen atom to which they are attached form 4-(2-hydroxyethyl) piperazino.

Claim 11

The compound of claim 1 having the formula ##STR30## in which: A represents CH 3 --CH< or dimethylene, R' represents OH and R" represents hydrogen, or R' and R", taken together, form an oxo radical (═O); R 6 represents hydrogen or methyl, and R' 7 represents --OR' 8 or ##STR31## R' 8 represents hydrogen or lower alkyl having 1-6 carbon atoms; r' represents hydrogen and r" represents lower alkyl having 1-6 carbon atoms.

Claim 12

The compound of claim 1 selected from the group consisting of: (1) (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl methyl benzoate; (2) (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl benzoic acid; (3) (5,8-methano-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl benzaldehyde; (4) (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl benzaldehyde; (5) (1,1,2,3,3-pentamethyl-5-indanyl)-4-carbonyl methyl benzoate; (6) (1,1,2,3,3-pentamethyl-5-indanyl)-4-carbonyl benzoic acid; (7) (1,1,2,3,3-pentamethyl-5-indanyl)-4-carbonyl benzaldehyde; (8) 1-(1,1,2,3,3-pentamethyl-5-indanyl)-1-(4-hydroxymethylphenyl) methanol; (9) (5,5,8,8-tetramethyl-5,6,7,8-tetrahydro)-2-naphthyl-4-hydroxymethyl benzoic acid; (10) (1,1,2,3,3-pentamethyl-5-indanyl)-4-hydroxymethyl benzoic acid; (11) (1,1,2,3,3-pentamethyl-5-indanyl)-4-hydroxymethylmethyl benzoate; (12) N-ethyl(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl benzamide; (13) N-ethyl(1,1,2,3,3-pentamethyl-5-indanyl)-2-carbonyl benzamide; (14) ethyl trans-(5,8-methano-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl cinnamate; (15) trans-(5,8-methano-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl cinnamic acid; (16) ethyl trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl cinnamate; (17) trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl cinnamic acid; (18) ethyl trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl-.alpha.-methyl cinnamate; (19) trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl-.alpha.-methyl cinnamic acid; (20) ethyl trans-(1,1,2,3,3-pentamethyl-5-indanyl)-4-carbonyl-α-methyl cinnamate; (21) trans-(1,1,2,3,3-pentamethyl-5-indanyl)-4-carbonyl-α-methyl cinnamic acid; (22) ethyl trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-hydroxymethyl-α-methyl cinnamate; (23) trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-hydroxymethyl-α-methyl cinnamic acid; (24) N-ethyl-trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-hydroxymethyl-α-methyl cinnamide; (25) N-ethyl-trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl-α-methyl cinnamide; (26) N-ethyl-trans-(1,1,2,3,3-pentamethyl-5-indanyl)-4-carbonyl-α-methyl cinnamide; (27) ethyl trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-hydroxymethyl cinnamate; (28) trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-hydroxymethyl cinnamic acid; (29) 4'-(2-hydroxyethyl)piperazino(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl) 4-carbonyl benzamide; (30) N-(3,5-di-trifluoromethyl-1-phenyl)-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl benzamide.

Claim 13

A method for preparing the compound of claim 1 comprising reacting an acid chloride having the formula, ##STR32## in an organic solvent medium with an aromatic compound having one of the following formulas: ##STR33## in which: A, R 1 -R 4 have the same meanings as those given in claim 1, R 8 being alkyl having from 1 to 20 carbon atoms, and X is Br or Cl, and optionally saponifying the resulting ketonic ester to the corresponding ketonic acid, and subsequently converting the said ketonic acid to the corresponding amide by the reaction with an amine having the formula: ##STR34## in which: r' and r" have the same meanings as those given in claim 1, or subsequently converting said ketonic acid to a hydroxy acid or to a diol with the optional oxidation of said diol to the corresponding ketonic aldehyde.

Claim 14

The method of claim 12, wherein the condensation reaction of said aromatic compound (2) is performed in the presence of anhydrous aluminum chloride in 1,2-dichloroethane at a temperature ranging from 0° to 25° C., while stirring the reaction mixture.

Claim 15

The method of claim 12, wherein the condensation of said acid chloride with the magnesium salt of formula (2') is performed at a temperature of about 0° C. in THF.

Claim 16

The method of claim 12, wherein the preparation of the amide is carried out in the presence of N,N'-carbonyl diimidazole.

Claim 17

The method of claim 12, wherein the reduction of the ketonic acid to the corresponding hydroxy acid is performed in the presence of sodium borohydride in THF.

Claim 18

The method of claim 12, wherein the ketonic aldehyde is obtained by oxidation of said diol using pyridinium chlorochromate, said corresponding diol resulting from a reduction reaction of said ketonic acid in the presence of aluminum lithium hydride.

Claim 19

A method of preparing the compound of formula I of claim 1 wherein n=0 and R=CHO, comprising reacting an acid chloride having the formula: ##STR35## in an organic solvent medium, under Friedel-Crafts reaction conditions with an aromatic compound having the formula: ##STR36## and liberating the aldehyde function by exchange with the glyoxal so as to obtain the expected ketonic aldehyde.

Claim 20

A method for preparing a compound having the formula: ##STR37## in which: R 1 -R 4 , R 6 and R 8 have the same meanings as in claim 1 comprising reacting a ketonic aldehyde having the formula: ##STR38## in which: A and R 1 -R 4 have the same meanings as in claim 1, with an alkyl phosphonoacetate having the formula: ##STR39## in the presence of sodium hydride in THF, and subjecting the resulting unsaturated keto ester to conventional reaction conditions so as to obtain the radicals in formula (I) given in claim 1.

Claim 21

A medicine comprising a compound of formula (I), as defined in claim 1 and a pharmaceutically acceptable vehicle.

Claim 22

The medicine of claim 20, administered in a daily dose of about 2 μg/kg to 2 mg/kg of body weight.

Claim 23

A pharmaceutical composition, comprising in a pharmaceutically acceptable vehicle, for enteral, parenteral, topical or ocular administration, at least one compound of formula (I) defined in claim 1.

Claim 24

The pharmaceutical composition of claim 22, in a form appropriate for topical or ocular application, said composition containing from 0.0005 to about 5% by weight of said compound based on the total weight of said composition.

Claim 25

A cosmetic composition for body and hair hygiene comprising in a cosmetically acceptable vehicle, at least one compound of formula (I) as defined in claim 1.

Claim 26

The cosmetic composition of claim 24, wherein said compound of formula (I) is present in an amount ranging from 0.0005 and 2% by weight, based on the total weight of said composition.

Claim 27

Trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl-α-methylcinnamic acid.

Claim 28

Trans-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-carbonyl-α-methylcinnamic acid.

Claim 29

A medicine comprising the compound of claim 26 and a pharmaceutically acceptable vehicle.

Claim 30

A pharmaceutical composition comprising in a pharmaceutically acceptable vehicle, for enteral, parenteral, topical or ocular administration, the compound of claim 26.

Claim 31

A cosmetic composition for body or hair hygiene comprising in a cosmetically acceptable vehicle, the compound of claim 26.